Mirati Therapeutics OverviewMirati Therapeutics Other Income Expense Net
Other Income/Expense Net for MRTX.
Quarterly Other Income/Expense
$10.15M
As of Sep 30, 2023
Annual Other Income/Expense (TTM)
$29.74M
Trailing 12 months ending Sep 30, 2023
Mirati Therapeutics OverviewOther Income/Expense Net for MRTX.
As of Sep 30, 2023
Trailing 12 months ending Sep 30, 2023